Sensoreal News
Sensoreal development of a Point of Care diagnostic device
Sensoreal is excited to announce that the company has begun working on the development of a Point of Care diagnostic device capable of differentiating between bacterial and viral infections. This project has been partially funded by Canada’s Innovative Solutions, answering the challenge to develop tools to combat the rise of Antimicrobial Resistance (AMR).
Sensoreal is excited to announce that the company has begun working on the development of a Point of Care diagnostic device capable of differentiating between bacterial and viral infections. This project has been partially funded by Canada’s Innovative Solutions, answering the challenge to develop tools to combat the rise of Antimicrobial Resistance (AMR). Link
Sensoreal awarded a contract from Canadian Food Inspection Agency
Sensoreal has been awarded a contract from Canadian Food Inspection Agency to develop a biosensor platform to detect Marine Biotoxin Detection Devices for Shellfish.
Sensoreal has been awarded a contract from Canadian Food Inspection Agency to develop a biosensor platform to detect Marine Biotoxin Detection Devices for Shellfish. Link
Sensoreal joins Creative Destruction Lab
Sensoreal has joined the Creative Destruction Lab.
Sensoreal has joined the Creative Destruction Lab.
Sensoreal welcomes Pooya Saberi
Sensoreal welcomes our new CPO, Pooya Saberi, M.Eng.
Sensoreal welcomes our new CPO, Pooya Saberi, M.Eng.
Sensoreal files patent
Sensoreal has filed a patent for the novel application of plasma polymer films to microfluidics.
Sensoreal has filed a patent for the novel application of plasma polymer films to microfluidics.
Sensoreal selected by MEDTEQ
Sensoreal has been selected by MEDTEQ and attended HOSPITALAR2019 in Brazil to demonstrate its technology.
Sensoreal has been selected by MEDTEQ and attended HOSPITALAR2019 in Brazil to demonstrate its technology.
Sensoreal cartridges tested at the International Space Station
Sensoreal cartridges were successfully tested at the International Space Station. Astronaut David Saint-Jacques has demonstrated that our microfluidic technology has the capacity to work reliably in zero gravity.
Sensoreal's microfluidic cartridges launched
Sensoreal's microfluidic cartridges were officially launched to the ISS by the resupply rocket NG-11.
Sensoreal's microfluidic cartridges were officially launched to the ISS by the resupply rocket NG-11. Link
Approval from Life Science Research Systems at Canadian Space Agency
The board members of Life Science Research Systems at Canadian Space Agency approved the commission of the microfluidic cartridge developed by Sensoreal. Congratulations to the team at Sensoreal for their 3 years of hard work.
The board members of Life Science Research Systems at Canadian Space Agency approved the commission of the microfluidic cartridge developed by Sensoreal. Congratulations to the team at Sensoreal for their 3 years of hard work. Link
Space Technology Development Program
Sensoreal successfully completed their contract through the Space Technology Development Program by the Canadian Space Agency to develop a portable nucleic acid detection system.
Sensoreal successfully completed their contract through the Space Technology Development Program by the Canadian Space Agency to develop a portable nucleic acid detection system. Link
Sensoreal contracted by Micronit
Sensoreal has been contracted by Micronit to develop a capillary driven microfluidic cartridge.
Sensoreal has been contracted by Micronit to develop a capillary driven microfluidic cartridge.
Sensoreal awarded 350,000$ to commercialize POC tests
Sensoreal has been awarded 350,000$ to commercialize POC tests to develop and commercialize instrument free direct bacteria capture platform by NRC Industrial Research Assistance Program (NRC-IRAP).
Sensoreal has been awarded 350,000$ to commercialize POC tests to develop and commercialize instrument free direct bacteria capture platform by NRC Industrial Research Assistance Program (NRC-IRAP).
Sensoreal awarded Space Technology Development Program
Sensoreal has been awarded a contract through Space Technology Development Program by the Canadian Space Agency to develop a portable nucleic acid detection system in collaboration with National Research Council Canada.
Sensoreal has been awarded a contract through Space Technology Development Program by the Canadian Space Agency to develop a portable nucleic acid detection system in collaboration with National Research Council Canada. Link
Sensoreal receives the Program Manager’s Commendation Award
Sensoreal has received the Program Manager’s Commendation Award in recognition of team’s dedication and the commitment to excellence and achievements in support of the Bioanalyzer project for carrying out blood tests on the International Space Station.
Sensoreal has received the Program Manager’s Commendation Award in recognition of team’s dedication and the commitment to excellence and achievements in support of the Bioanalyzer project for carrying out blood tests on the International Space Station. Link
Dr. Roozbeh Safavieh, interviewed on BBC
Dr. Roozbeh Safavieh, Sensoreal's CEO, was interviewed on BBC radio (49 min - 52 min) about the development of a low-cost microchip to diagnose the causes of persistent diarrheal diseases.
Dr. Roozbeh Safavieh, Sensoreal's CEO, was interviewed on BBC radio (49 min - 52 min) about the development of a low-cost microchip to diagnose the causes of persistent diarrheal diseases. Link
Sensoreal’s Urine Chip won First Place in Shark Tank
Sensoreal’s Urine Chip won First Place in the Shark Tank Competition in both Judges’ Voting and People’s Choice Categories.
Sensoreal’s Urine Chip won First Place in the Shark Tank Competition in both Judges’ Voting and People’s Choice Categories.
Sensoreal receives a Grand Challenges Canada
Sensoreal received a Grand Challenges Canada grant to develop low-cost microchips to diagnose the cause of persistent diarrhoeal diseases in children. Link
Sensoreal received a Grand Challenges Canada grant to develop low-cost microchips to diagnose the cause of persistent diarrhoeal diseases in children. Link
Sensoreal awarded contract to develop microchip for blood tests
Sensoreal was awarded a contract to develop a microchip for blood tests on the International Space Station in collaboration with Honeywell Aerospace, Alentic Microscience, and the Canadian Space Agency. Link
Sensoreal was awarded a contract to develop a microchip for blood tests on the International Space Station in collaboration with Honeywell Aerospace, Alentic Microscience, and the Canadian Space Agency. Link